Allurion Technologies, Inc. Other Noncash Income (Expense)
Allurion Technologies, Inc. (ALUR) reported Other Noncash Income (Expense) of $582.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-11-17
- Allurion Technologies, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was -$269.00K, a 166.92% decline year-over-year.
- Allurion Technologies, Inc. other noncash income (expense) for the quarter ending 2024-09-30 was $402.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month |
|---|---|---|---|
| 2025-09-30 | -$269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $582.00K 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $851.00K 10-Q · filed 2025-08-19 | ||
| 2024-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $29.00K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | -$373.00K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |